Deadline: 30-Oct-23
How can everyone responsibly and equitably use AI in health to accelerate basic research, diagnose conditions, develop novel treatments, predict and prevent disease, and lead to better health outcomes and cures? MIT Solve is accepting solutions for the Cure Xchange Challenge – Health AI for Good.
The Cure Xchange Challenge seeks U.S.-based applicants who are working across disciplines and sectors on innovative, Equitable AI solutions for better health outcomes through improvements in:
- Collecting, analyzing, curating, and making sense of big data to ensure high-quality inputs, outputs, and insights.
- Using data sharing and interoperability of systems.
- Creating models and systems that process massive data sets to identify specific targets for precision drugs and treatments.
- Developing and refining models that use high-quality data to predict and personalize a person’s future health risks with plans to prevent or reduce these risks.
- Augmenting and assisting human caregivers.
- Creating and streamlining human-centered processes for delivering, providing equitable access to, managing and paying for healthcare.
- Creating user-friendly interfaces to improve communication between experts and patients, including providing better information, results, and reminders.
- Creating a versatile data framework that connects broadly disparate, multimodal data sets to identify patterns or insights to serve as hypotheses for improvements in health systems or global surveillance systems.
What winners will receive?
- Do you have a solution that addresses health AI for good in the US?
- Winners will receive:
- Seed money from a pool of up to $1 million, which includes prize money and in-kind resources including lab space, mentorship, and support programming
- 1 Year Residency at Cure’s second floor or wet labs in the heart of New York City
- Mentoring from Cure’s Executive Advisory Board and connections to renowned entrepreneurs, public health experts, and executives
- Access to the Cure ecosystem, which provides educational programming, visibility, and networking opportunities with cross-sectoral experts and venture capitalists
What type of solutions are eligible?
Early-stage solutions include:
- Concept: An idea being explored for its feasibility to build a product, service or business model based on that idea.
- Prototype: A solution or organization that is building and testing its product, service or business model. If for-profit, a new company getting off the ground that has raised little or no institutional capital (less than $500,000) in pre-seed fundraising.
- Pilot: A solution or organization that is deploying a tested product, service or business model in at least one community. If for-profit, a young company that is working to gain traction and that has raised less than $2 million in institutional capital in seed funding.
Who can apply?
- Applicants must be U.S.-based and/or willing and able to participate in a one-year New York City-based Cure Residency starting February 2024. U.S. visa sponsorship for the Cure Residency is not provided by Cure, Deerfield Management Company or MIT Solve. Innovators in Residence must be able to reside in New York City on their own accord.
- Applicants can be an individual, student, team, or an early-stage organization of any type, including but not limited to nonprofit, for-profit, or hybrid organizations. U.S. law prevents MIT Solve from awarding funds to persons ordinarily resident in Iran, Cuba, Syria, North Korea, Crimea, Russia or Belarus, or from parties blocked by the U.S. Treasury Department.
- Applicants to previous MIT Solve Challenges are invited to apply.
For more information, visit MIT Solve.